USE OF HIGH-DOSE ETOPOSIDE IFOSFAMIDE CARBOPLATIN EPIRUBICIN AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN LIMITED-DISEASE SMALL-CELL LUNG-CANCER
W. Brugger et al., USE OF HIGH-DOSE ETOPOSIDE IFOSFAMIDE CARBOPLATIN EPIRUBICIN AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN LIMITED-DISEASE SMALL-CELL LUNG-CANCER, Seminars in oncology, 22(1), 1995, pp. 3-8